• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

热搜关键词: 奎宁水 楚天科技 氯化钠注射液 江苏恩华药业股份有限公司 左旋咪唑 >>

您的位置:首页 >> 资讯 >> 专题策划 >> 引领医药行业的数字科技 | Pharma Sources Insight第六期

引领医药行业的数字科技 | Pharma Sources Insight第六期

https://www.cphi.cn   2021-08-09 17:29 来源:CPhI制药在线 作者:PharmaSourcesInsig

Your FREE source of news and insights into China pharmaceutical industry!

Pharma Sources Insight

       Pharma Sources Insight

       Your FREE source of news and insights into China pharmaceutical industry, and more!

扫码开始阅读 Scan to view the full contents.

扫码开始阅读

Scan to view the full contents.

Pharma Sources Insight

August 2021

       Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

       Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

 

       Pharma Sources Insight August 2021 focuses on the following topics:

       ►BRAND STORY

       -Product Lists of Nanjing Foreign Economic & Trade Development Co., Ltd.

       ►FIGHTING AGAINST 

          COVID-19

       -Which One of the New Dosage Forms of Nasal Spray Vaccine for COVID-19 Will Be Successful?

       -Overview of COVID-19 Vaccination in Progress in China

       -Having Applied for IPO to HKEX, What to Expect on Advaccine R&D Pipelines beyond COVID-19 DNA Vaccine

       -Science of Epidemiology: Digital Technologies Shaping Our Lives

       ►GLOBAL MARKET REVIEW

       -Alzheimer’s Disease - Recent Advances in Treatment

       -India’s Pharmaceutical Industry Disruption Impacts Africa and the World

       ►PHARMA IN CHINA

       -Popular Products and Suppliers at PharmaSources.com

       -Overseas Marketing of Furmonertinib Following Avitinib and Almonertinib

       -Bispecific Antibodies – Key Developments in China

       ►INDUSTRY INSIGHT

       -A Brief Introduction About FDA Next Step Inspections

往期回顾

August 2021

Pharma Sources Insight April 2021

第五期:https://flbook.com.cn/c/UvEylKXA3d

Pharma Sources Insight January2021

第四期:https://flbook.com.cn/c/hiKJryuATA

第二十一届世界制药原料中国展

版权所有,未经允许,不得转载。

市场动态更多 >>
主编视角更多 >>
热门标签更多

投稿合作联系方式: Kelly.Xiao@imsinoexpo.com 021-33392297

地址:上海市徐汇区虹桥路355号城开国际大厦7-8楼 200030

CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)